These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3266023

  • 21. Patterns of MHC class II antigen expression (HLA-DR, DP, and DQ) on peripheral blood T lymphocytes in patients after liver transplant.
    Winkler M, Schwinzer R, Wonigeit K.
    Transplant Proc; 1989 Aug; 21(4):3627-8. PubMed ID: 2669267
    [No Abstract] [Full Text] [Related]

  • 22. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM.
    J Exp Med; 1986 Oct 01; 164(4):1013-28. PubMed ID: 2428913
    [Abstract] [Full Text] [Related]

  • 23. MHC class II antigen expression in normal human epidermis.
    Carr MM, McVittie E, Guy K, Gawkrodger DJ, Hunter JA.
    Immunology; 1986 Oct 01; 59(2):223-7. PubMed ID: 2429921
    [Abstract] [Full Text] [Related]

  • 24. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS, Baadsgaard O, Hammerberg C, Cooper KD.
    J Immunol; 1991 Dec 01; 147(11):3794-802. PubMed ID: 1719088
    [Abstract] [Full Text] [Related]

  • 25. T-cells and HLA-class II expression in the large intestine of infants in the early postnatal period.
    Ormälä T, Rintala R, Savilahti E.
    J Pediatr Gastroenterol Nutr; 1998 Apr 01; 26(4):422-8. PubMed ID: 9552138
    [Abstract] [Full Text] [Related]

  • 26. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G, Schneider EM, Müller C, Wernet P.
    Eur J Immunol; 1985 Jan 01; 15(1):12-7. PubMed ID: 2578396
    [Abstract] [Full Text] [Related]

  • 27. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
    Faure M, Frappaz A, Schmitt D, Dezutter-Dambuyant C, Thivolet J.
    Cell Immunol; 1984 Feb 01; 83(2):271-9. PubMed ID: 6229342
    [Abstract] [Full Text] [Related]

  • 28. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
    Hughes RG, Norval M, Howie SE.
    J Clin Pathol; 1988 Mar 01; 41(3):253-9. PubMed ID: 2834416
    [Abstract] [Full Text] [Related]

  • 29. Effect of UVA and PUVA on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells.
    Mørk NJ, Gaudernack G, Braathen LR.
    Photodermatol; 1987 Apr 01; 4(2):66-72. PubMed ID: 3498937
    [Abstract] [Full Text] [Related]

  • 30. In vivo retinoic acid modulates expression of the class II major histocompatibility complex and function of antigen-presenting macrophages and keratinocytes in ultraviolet-exposed human skin.
    Meunier L, Voorhees JJ, Cooper KD.
    J Invest Dermatol; 1996 May 01; 106(5):1042-6. PubMed ID: 8618036
    [Abstract] [Full Text] [Related]

  • 31. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
    Hansen ER, Baadsgaard O, Lisby S, Cooper KD, Thomsen K, Vejlsgaard GL.
    J Invest Dermatol; 1990 Apr 01; 94(4):485-91. PubMed ID: 1968933
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. UV sensitivity of human keratinocyte and Langerhans cell-expressed HLA-DR antigens: a comparison.
    Koulu L, Jansén CT.
    Photodermatol; 1987 Aug 01; 4(4):176-81. PubMed ID: 2448759
    [Abstract] [Full Text] [Related]

  • 34. Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin.
    Sewell HF, Thomson AW, Walker F, King G, Abramovich DR.
    Tissue Antigens; 1986 Jul 01; 28(1):41-5. PubMed ID: 3529495
    [Abstract] [Full Text] [Related]

  • 35. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L, Vian L, Lagoueyte C, Lavabre-Bertrand T, Duperray C, Meynadier J, Cano JP.
    Cytometry; 1996 Dec 15; 26(4):260-4. PubMed ID: 8979024
    [Abstract] [Full Text] [Related]

  • 36. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
    Lisby S, Baadsgaard O, Cooper KD, Hansen ER, Mehregan D, Thomsen K, Allen E, Lange Vejlsgaard G.
    Scand J Immunol; 1990 Aug 15; 32(2):111-9. PubMed ID: 1697095
    [Abstract] [Full Text] [Related]

  • 37. Expression of HLA class II antigens in marginal periodontitis of patients with Down's syndrome.
    Søhoel DC, Johannessen AC, Kristoffersen T, Nilsen R.
    Eur J Oral Sci; 1995 Aug 15; 103(4):207-13. PubMed ID: 7552950
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma. An immunohistochemical study.
    Valcuende-Cavero F, Febrer-Bosch MI, Castells-Rodellas A.
    Acta Derm Venereol; 1994 May 15; 74(3):183-7. PubMed ID: 7521102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.